4.6 Article

Cause of Death in Older Men After the Diagnosis of Prostate Cancer

Journal

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Volume 57, Issue 1, Pages 24-30

Publisher

WILEY
DOI: 10.1111/j.1532-5415.2008.02091.x

Keywords

prostate cancer; mortality; survival and comorbidities

Funding

  1. U. S. Public Health Service [5P50CA105631, 5P30AG024824, 5R01CA 116758]
  2. National Institute on Aging [5T35AG026778]
  3. NATIONAL CANCER INSTITUTE [P50CA105631, R01CA116758] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE ON AGING [P30AG024824, P30AG024832, T35AG026778] Funding Source: NIH RePORTER

Ask authors/readers for more resources

To compare survival and cause of death in men aged 65 and older diagnosed with prostate cancer and with survival and cause of death in a noncancer control population. Retrospective cohort from a population-based tumor registry linked to Medicare claims data. Eleven regions of the Surveillance, Epidemiology and End Results (SEER) Tumor Registry. Men aged 65 to 84 (N=208,601) diagnosed with prostate cancer from 1988 through 2002 formed the basis for different analytical cohorts. Survival as a function of stage and tumor grade (low, Gleason grade < 7; moderate, grade=7; and high, grade=8-10) was compared with survival in men without any cancer using Cox proportional hazards regression. Cause of death according to stage and tumor grade were compared using chi-square statistics. Men with early-stage prostate cancer and with low- to moderate-grade tumors (59.1% of the entire sample) experienced a survival not substantially worse than men without prostate cancer. In those men, cardiovascular disease and other cancers were the leading causes of death. The excellent survival of older men with early-stage, low- to moderate-grade prostate cancer, along with the patterns of causes of death, implies that this population would be well served by an ongoing focus on screening and prevention of cardiovascular disease and other cancers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available